Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Practical Neurology|September 24, 2024
Investigating secondary hypertension in cerebrovascular diseaseClaudia Zeicu, Marie Fisk, Nicholas Richard Evans
Plos One|November 1, 2021
Role of the IL-33/ST2 axis in cardiovascular disease: A systematic review and meta-analysisYuan Sun, Holly Pavey, Ian Wilkinson, et al.
European Journal of Radiology|July 24, 2020
Advances in PET to assess pulmonary inflammation: A systematic reviewLaurence Vass, Marie Fisk, Sarah Lee, et al.
EJNMMI Physics|December 18, 2019
Reproducibility of compartmental modelling of <sup>18</sup>F-FDG PET/CT to evaluate lung inflammationLaurence D Vass, Sarah Lee, Frederick J Wilson, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|February 8, 2014
Therapeutic potential of p38 MAP kinase inhibition in the management of cardiovascular diseaseMarie Fisk, Parag R Gajendragadkar, Kaisa M Mäki-Petäjä, et al.
British Journal of Clinical Pharmacology|November 15, 2021
Sustainable medicines use in clinical practice: A clinical pharmacological view on eco-pharmaco-stewardshipElizabeth Adeyeye, Benjamin Jaa Ming New, Fangyue Chen, et al.
Immunotherapy Advances|April 9, 2025
Lung immune challenge study protocol: controlled exposure to inhaled resiquimod (R848) to study mechanisms of inflammationAkhilesh Jha, Marie Fisk, Jamie Forrester, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|December 19, 2018
Inaccurate diagnosis of COPD: the Welsh National COPD AuditMarie Fisk, Viktoria McMillan, James Brown, et al.
Trials|July 16, 2020
Correction to: ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trialCarmel M McEniery, Marie Fisk, Karen Miles, et al.
Trials|July 4, 2020
ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trialCarmel M McEniery, Marie Fisk, Karen Miles, et al.
Pageof 4